Latest News

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

340B program drifted from patient benefit; federal reform needed for transparency and accountability.

CANN marks 30th anniversary with expanded partnerships and cross-condition advocacy evolution.

Lupus Colorado partnership with CANN demonstrates how disease-specific and multi-condition advocates amplify healthcare policy impact.

Pharmaceutical industry engagement of patient advocates requires transparency about funding, conflicts of interest, and advocacy independence.

Reflection on advocacy values and health equity commitment during political transitions.

World AIDS Day reflection on ending the HIV epidemic: challenges and opportunities.

Pugh reflects on 340B policy and patient advocacy in ensuring equitable medication access.

Research on elevated cancer risks in PLWHA and importance of early detection.

State-level PDAB implementation advancing despite patient advocacy concerns.

World AIDS Day 35th anniversary: centering PLWH voices and investing in lived-experience leadership.

PDAB state implementation variations and how patients can engage in the process.

Payers face regulatory scrutiny for systematic coverage denials and prior authorization abuse.

Introduction to PDABs: structure, function, and importance for patient medication access.

340B reform must prioritize patients: charity care obligations and medical debt reduction.

Nashville Fireside Chat: state funding cuts, 340B reform, and HIV criminalization law changes.

2023 outlook: CVS PBM discrimination lawsuit, Medicaid enforcement, and state-sponsored discrimination threats.

S.4395 would divert Ryan White resources from PLWHA to PrEP, threatening the safety net for vulnerable populations.

European Commission approves lenacapavir, a novel six-month injectable for treatment-resistant HIV.

Sustainable advocacy requires long-term investment beyond quarterly financial commitments.